AIIMS New Delhi advertises for Phase-III clinical trial of Covaxin

AIIMS New Delhi advertises for Phase-III clinical trial of Covaxin "AIIMS, New Delhi is a site for COVAXIN Phase III clinical trial. This is a whole-virion inactivated vaccine co-sponsored by Indian Council of Medical Research (ICMR) and Bharat Biotech," AIIMS said in an advertisement. https://ift.tt/eA8V8J